Following are EIFBCR Symposium Attendees:

Karen Antman, MD
Columbia Presbyterian Medical Center

Alan Ashworth, PhD
Breakthrough Toby Robins Breast Cancer Research Centre,
The Institute for Cancer Research, Chester Beatty Laboratories, London

Harry Bartelink, MD, Ph.D
Professor and Chairman, Department of Raditherapy, The Netherlands Cancer Institute, Amsterdam, The Netherlands

Chris Benz, MD
Buck Institute for Age Research, Professor and Director, Program of Cancer and Developmental Therapeutics

Mina Bissell, PhD
Lawrence Berkeley National Laboratory

Blake Cady, MD
Women’s & Infant Hospital, The Breast Health Center

Jenny Chang, MD
Associate Professor, Department of Medicine, Breast Center, Baylor College of Medicine

Arul Chinnaiyan, MD, PhD
Assistant Professor, University of Michigan Health System, Department of Pathology

Gary Clark, Ph.D.
Baylor College of Medicine

Leena Hilakivi-Clarke, PhD
Georgetown University Medical Center

Michael Clarke, MD
University of Michigan Health System, Internal Medicine & Dev. Biology and Stanford Comprehensive Cancer Center

Donald Cleveland, Ph.D.
Ludwig Institute for Cancer Research, University of California San Diego

Suzanne Conzen, MD
University of Chicago Medical Center

Dorraya El-Ashry, PhD
Assistant Professor, Department of Internal Medicine, University of Michigan Health System

Laura Esserman, MD
University California San Francisco Mt. Zion Cancer Center

Gini F. Fleming, MD
University of Chicago Medical Center

David A. Flockhart, MD, PhD
Chief, Division of Clinical Pharmacology, Indiana University Cancer Center

Barbara Fowble, MD
Fox Chase Cancer Institute

Suzanne Fuqua, PhD
Baylor College of Medicine

Judy Garber, MD
Dana Farber Cancer Institute

Teresa Gilewski, MD
Cornell University Medical College

William J. Gradishar, MD
Northwestern University Medical School, Director of Breast Medical Oncology, Robert H. Lurie Comprehensive Cancer Center

Joe Gray, PhD
University of California, San Francisco Cancer Center, Department of Laboratory Medicine, Lawrence Berkeley National Laboratory

Geoffrey Greene, MD
Ben May Institute for Cancer Research, University of Chicago

Adrian Harris, MD, PhD
Churchill Hospital, ICRF Clinical Oncology Unit, Oxford, England

Daniel Hayes, MD
Professor of Medicine, Director, Breast Oncology Program, University of Michigan Medical Center

Ruth Heimann, MD
Associate Professor, Department of Radiation and Cellular Oncology, University of Chicago

Brian Henderson, MD
University of Southern California

Craig Henderson, MD
ALZA

Lothar Hennighausen, PhD
NIDDK, National Institutes of Health

Ronald Herberman, MD
Pittsburgh Cancer Institute

Jeffrey Holt, MD
Vanderbilt University Medical Center

Robert Hoover, MD
National Cancer Institute

William Hryniuk, MD
Karmanos Cancer Institute

Clifford Hudis, MD
Chief, Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center

Stephanie Jeffrey, MD
Stanford University

Robert Kerbel, MD
Molecular & Cell Biology Research, Sunnybrook & Women’s College Health, Science Center, University of Toronto

Joshua LaBaer, MD, PhD
Director, Harvard Institute of Proteomics, Department of Biological Chemistry and Molecular Pharmacology, Whitehead Institute Center for Genome Research, Harvard Medical School

Marc Lippman, MD
Georgetown Medical School

Michael T. Lotze, MD
University of Pittsburgh

David Mankoff, MD, PhD
University of Washington Medical Center, Division of Nuclear Medicine and Radiology

John Mendelsohn, MD
M.D. Anderson Cancer Center

Malcolm Mitchell, MD
Karmanos Cancer Institute

Asa Joel Nixon, MD, MPH
Harvard Medical School

Olufunmilayo Olopade, MD
University of Chicago, Cancer Risk Center

Michael O’Reilly, MD
Harvard Medical School

C. Kent Osborne, MD
Director of Breast Center, Baylor College of Medicine

Soonmyung Paik, MD
NSABP Foundation

John Park, MD
University of California San Francisco, Mount Zion Cancer Center, William Peters, MD, PhD, Karmanos Cancer Institute

Mark Pegram, MD
Hematology/Oncology, Miller School of Medicine, University of Miami

Edith Perez, MD
Mayo Clinic Jacksonville

Charles Perou, PhD
Department of Genetics and Pathology, Lineberger Comprehensive Cancer Center, University of North Carolina

Malcolm Pike, PhD
University of Southern California Keck School of Medicine, University of California Norris Comprehensive Cancer Center

Peggy Porter, MD
Fred Hutchinson Cancer Research Center

Mitchell C. Posner, MD
Department of Surgery University of Chicago

Michael F. Press, MD, PhD
University of Southern California, Norris Comprehensive Cancer Center, Co-Director of the Breast Center Research Program

Leonard Prosnitz, MD
Duke University Medical School

Lajos Pusztai, MD, PhD
University of Texas, MD Anderson Cancer Center

James Rae, PhD
Department of Internal Medicine, University of Michigan Health System

Nicholas Restifo, MD
National Cancer Institute

Neal Rosen, MD
Memorial Sloan-Kettering Cancer Center

Joseph Rosenblatt, MD
Division of Hematology-Oncology, Sylvester Cancer Center
University of Miami

Erkki Ruoslahti, MD
The Burnham Institute

Richard Santen, MD
Aurbach Medical Research Building, University of Virginia Health Sciences System

Daniela Santoli, MD
The Wistar Institute

George W. Sledge, Jr., MD
Ballve-Lantero Professor of Oncology, Indiana University Cancer Center

Joyce Slingerland, MD, PhD
Director, Braman Family Breast Cancer Institute, Sylvester Comprehensive Cancer Center, Batchelor Children’s Institute
University of Miami

Patricia Steeg, Ph.D.
Department of Pathology, National Cancer Institute

Sonia Sugg, MD
University of Chicago

George Vande Woude, PhD
Van Andel Research Institute

Laura Van’t Veer, PhD
The Netherlands Cancer Institute, Department of Pathology, Amsterdam, Netherlands

Shaomeng Wang, PhD
University of Michigan Health System, Internal Medicine/Hematology Oncology

Ralph R. Weichselbaum, MD
Daniel K. Ludwig Professor and Chairman, Department of Radiobiology and Cell Oncology, The University of Chicago
The Center for Advanced Medicine

Louis Weiner
Fox Chase Cancer Center

Stephen Weiss, MD
Division Chief-Molecular Medicine and Genetics, Department of Internal Medicine, University of Michigan

Anton Wellstein, MD, PhD
Georgetown University

Max Wicha, MD
Professor, Department of Internal Medicine, Distinguished Professor of Oncology, University of Michigan Health System
Comprehensive Cancer Center

Rod Withers, MD
University of California Los Angeles

Savio Woo
Mount Sinai Medical Center

John Wunderlich, MD
National Cancer Institute

Bruce Zetter, Ph.D.
Department of Cell Biology, Children’s Hospital, Harvard Medical School